Metastatic neoplasms in the larynx from remote primary tumors are uncommon, and laryngeal metastasis originating from the colorectum is extremely rare. We herein report a case of metastatic laryngeal carcinoma originating from sigmoid colon cancer in a 54 -yearold female. Curative partial laryngectomy was performed, and the patient remains alive with a good quality of life and no signs of recurrence seven years and eight months after sigmoidectomy and four years and eight months after partial laryngectomy.
INTRODUCTION
Secondary laryngeal cancers are very rare tumors, with an incidence ranging from 0.09% to 0.4% of all laryngeal neoplasms. Among these lesions, skin melanoma and renal cell carcinoma are the most frequent sites of origin 1) . However, colorectal carcinoma (CRC) metastases to the larynx are extremely rare ; there are only 12 cases of secondary laryngeal tumors originating from CRC.
We herein report a case of sigmoid colon cancer metastasis to the lungs and larynx that was successfully resected and discuss the characteristics of metastatic laryngeal tumors. To our knowledge, this case is the only reported case of longterm survival in a patient with this disease.
CASE REPORT
In November 2005, a 54 -yearold Japanese female underwent sigmoidectomy with lymph node dissection under a diagnosis of sigmoid colon cancer. The postoperative TNM classification was Stage IIIB disease (T3N1M0) and histopathological findings were moderately differentiated adenocarcinoma ( Fig. 1a ). Postoperative adjuvant FOLFOX4 (oxali-platin plus an infusion of 5 -fluorouracil /levofolinate) therapy was administered for 11 cycles. In May 2008, a computed tomography (CT) scan of the thorax showed a 2 cm nodular mass in the right middle lung. Consistent with the CT findings, positron emission tomography (PET) demonstrated high uptake of FDG in the right middle lung. There were no abnormal areas of uptake in either the anastomotic lesion or regional lymph nodes. Therefore, middle lobectomy of the right lung was performed under a diagnosis of lung metastasis. The histopathological findings were well differentiated adenocarcinoma, consistent with a diagnosis of metachronous lung metastasis of sigmoid colon carcinoma ( Fig. 1b) .
In November 2008, the patient was admitted to our clinic with a 2 -week history of hoarseness. On admission, she looked well. Her body temperature, arterial blood pressure and respirations were normal. A physical examination showed no abnormal findings. Laboratory tests were normal, and the carcinoembryonic antigen level was 2.9 μg/L (normal range : <5.0 μg/L).
Laryngoscopy revealed a nodular mass in the right subglottic lesion (Fig. 2) . A histological examina tion of laryngoscopic biopsy specimens revealed suspected metastasis from sigmoidal adenocarcinoma. A further workup did not reveal any other sites of metastatic spread. Therefore, the patient underwent partial laryngectomy at another institution. The pathological specimen exhibited moderately differentiated adenocarcinoma, consistent with a diagnosis of metastasis from sigmoidal adenocarcinoma ( Fig. 1c ). Additional chemotherapy with S1 was administered at 100 mg/day over six months. The patient remains alive with a good quality of life at seven years and six months after the initial surgery, and four years and six months after partial laryngectomy, respectively. Moreover, posttreatment annual CT scan showed no recurrent disease.
DISCUSSION
Colorectal cancer is a major cause of death worldwide, and its incidence has been increasing over the past 25 years 2 -4) .
With the increasing use of new radiologic modalities, such as CT, magnetic resonance imaging (MRI) and PET, together with the increasing survival rates of patients with primary colorectal cancer, metastasis is more likely to be diagnosed.
Common metastatic sites for adenocarcinoma of the colon and rectum include the liver and the lungs, whereas metastasis to the larynx is very rare. Metastatic neoplasms in the larynx are unusual, accounting for 0.09% to 0.4% of all laryngeal tumors 1) . On the other hand, Friedmann and Osborn 5) reported that 23.9% of patients with metastasis to the head and neck have laryngeal and/or tracheal diseases at autopsy. The difference in the frequency of this disease in clinical and autopsy cases suggests the possibility that the actual clinical prevalence of laryngeal metastasis has been underestimated.
To the best of our knowledge, only 12 cases, including our case, of metastasis of CRC have been reported in the English language literature (Table 1) 6 -15) .
Based on the cases with available information, laryngeal metastases have the following characteris- 16) . The vertebral venous plexus has also been implicated in retrograde metastatic spread of colorectal cancer 17) . The high incidence of lung metastasis in the patients with laryngeal metastasis strongly sug-gests a metastatic route from the lungs to the larynx.
Since no general rules can be established on how to treat secondary laryngeal tumors due to their rare nature, the treatment approach must be tailored to the individual patient based on the biologic behavior of the primary tumor, the characteristics of the laryngeal lesion, the general condition of the patient and the results of the metastatic workup, which must include CT, PET and bone scintigraphy as long as possible.
A general recommendation, however, can be made that symptomatic and palliative treatment should be administered in patients with multiple metastases, including those in the larynx. Options for intervention include bronchoscopy, direct laryngoscopy with laser excision, and debulking of the laryngeal tumor. Tracheostomy can be performed in patients with significant respiratory distress due to airway obstruction. A reasonable chance for curative treatment can be expected only in patients with solitary laryngeal metastases. Therefore, adjuvant therapy was done only in our present case. The prognosis of patients with laryngeal metastasis is poor because laryngeal involvement is generally observed in terminal patients with other multiple metastases. The longest survival after treatment for laryngeal metastases originating from CRC was observed in our patient. Curative treatment for laryngeal metastasis of primary CRC with an appropriate adjuvant chemotherapy may prolong the survival of carefully selected patients.
CONCLUSION
While the incidence is low, patients with a history of CRC, lung metastasis and symptoms of hoarseness, dyspnea, dysphonia, and stridor should be evaluated for the possibility of metastasis to the larynx.
A thorough investigation for metastasis to other organs should also be performed.
